SCHEMBL19625367

SCHEMBL19625367

CCN(CC)c1ccc(-c2csc(C(C)(C)C)n2)cc1F

nearest known ligand 0.40

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
CYP3A4 P08684 3/20 0.40
ALDH1A1 P00352 5/20 0.39
RAB9A P51151 2/20 0.39
MEN1 O00255 1/20 0.39
NPC1 O15118 1/20 0.39
KMT2A Q03164 1/20 0.39
SMN1; SMN2 Q16637 1/20 0.39
PSEN1 P49768 6/20 0.38
PSEN2 P49810 6/20 0.38
APH1B Q8WW43 6/20 0.38
NCSTN Q92542 6/20 0.38
APH1A Q96BI3 6/20 0.38
PSENEN Q9NZ42 6/20 0.38
CYP2C19 P33261 1/20 0.38
COMT P21964 1/20 0.37
MPL P40238 1/20 0.36
POLB P06746 2/20 0.36
CYP11B1 P15538 1/20 0.36
CYP11B2 P19099 1/20 0.36
L3MBTL1 Q9Y468 1/20 0.36

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL19626497 0.85 ALDH1A1 (0.49) CYP3A4ALDH1A1RAB9AMEN1NPC1
SCHEMBL19625369 0.85 MAPT (0.38) CYP3A4ALDH1A1RAB9AMEN1NPC1
SCHEMBL19625433 0.84 CDC25A (0.39) ALDH1A1RAB9AMEN1NPC1KMT2A
SCHEMBL2573085 0.83 RAB9A (0.57) CYP3A4ALDH1A1RAB9AMEN1NPC1
SCHEMBL19625441 0.82 ABL1 (0.38) CYP3A4ALDH1A1RAB9AMEN1NPC1
SCHEMBL19626611 0.81 GAA (0.40) ALDH1A1RAB9AMEN1KMT2ASMN1; SMN2
SCHEMBL19625390 0.81 LATS1 (0.35) ALDH1A1RAB9AMEN1NPC1KMT2A
SCHEMBL19625435 0.79 CDC25A (0.39) ALDH1A1RAB9AMEN1NPC1KMT2A
SCHEMBL19625374 0.79 GFER (0.43) CYP3A4ALDH1A1RAB9AMEN1NPC1
SCHEMBL19625501 0.79 COMT (0.36) CYP3A4ALDH1A1RAB9AMEN1NPC1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-10472360-B2 Purine diones as Wnt pathway modulators AGENCY FOR SCIENCE, TECHNOLOGY AND RESEARCH (SG) 2019-11-12 US disclosed
US-20170334912-A1 Purine Diones As Wnt Pathway Modulators AGENCY FOR SCIENCE, TECHNOLOGY AND RESEARCH (SG) 2017-11-23 US disclosed
US-20170334912-A1 Purine Diones As Wnt Pathway Modulators AGENCY FOR SCIENCE, TECHNOLOGY AND RESEARCH (SG) 2017-11-23 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20170334912-A1 Purine Diones As Wnt Pathway Modulators WNT1, WNT3A, CTNNB1 CYP3A4 419/4885ALDH1A1 1166/4885RAB9A 3162/4885
US-10472360-B2 Purine diones as Wnt pathway modulators WNT1, WNT3A, CTNNB1 CYP3A4 419/4885ALDH1A1 1166/4885RAB9A 3162/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.